Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Martina Mazzeschi
Observed names:
M Mazzeschi,
M. Mazzeschi,
Mazzeschi M,
Mazzeschi, Martina
Institution:
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola
Observed institutions:
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola,
University of Bologna
ORCID:
0000-0002-4695-9175
Observed ORCID:
0000-0002-4695-9175
OpenAlex ID:
A5047679868
Roles of IL-1 in Cancer: From Tumor Progression to Resistance to Targeted Therapies
2020
·
Valerio Gelfo
, Donatella Romaniello
, et al.
·
International Journal of Molecular Sciences
·
197
PDF
Glucocorticoid receptor antagonization propels endogenous cardiomyocyte proliferation and cardiac regeneration
2022
·
Nicola Pianca
, Francesca Sacchi
, et al.
·
Nature Cardiovascular Research
·
43
PDF
BMP7 promotes cardiomyocyte regeneration in zebrafish and adult mice
2024
·
Chiara Bongiovanni
, Hanna Bueno-Levy
, et al.
·
Cell Reports
·
42
A Novel Role for the Interleukin-1 Receptor Axis in Resistance to Anti-EGFR Therapy
2018
·
Valerio Gelfo
, Martina Mazzeschi
, et al.
·
Cancers
·
38
PDF
The autocrine loop of ALK receptor and ALKAL2 ligand is an actionable target in consensus molecular subtype 1 colon cancer
2022
·
Martina Mazzeschi
, Michela Sgarzi
, et al.
·
Journal of Experimental & Clinical Cancer Research
·
24
PDF
Senescence-associated reprogramming induced by interleukin-1 impairs response to EGFR neutralization
2022
·
Donatella Romaniello
, Valerio Gelfo
, et al.
·
Cellular & Molecular Biology Letters
·
21
PDF
Extracellular Vesicles and Epidermal Growth Factor Receptor Activation: Interplay of Drivers in Cancer Progression
2023
·
Enea Ferlizza
, Donatella Romaniello
, et al.
·
Cancers
·
19
A new method for the study of biophysical and morphological parameters in 3D cell cultures: Evaluation in LoVo spheroids treated with crizotinib
2021
·
Azzurra Sargenti
, Francesco Musmeci
, et al.
·
PLoS ONE
·
16
PDF
Glucocorticoid Receptor Modulates EGFR Feedback upon Acquisition of Resistance to Monoclonal Antibodies
2019
·
Valerio Gelfo
, Francesca Pontis
, et al.
·
Journal of Clinical Medicine
·
12
PDF
Aberrant MET activation impairs perinuclear actin cap organization with YAP1 cytosolic relocation
2023
·
Michela Sgarzi
, Martina Mazzeschi
, et al.
·
Communications Biology
·
10
A humanized anaplastic lymphoma kinase (ALK)-directed antibody-drug conjugate with pyrrolobenzodiazepine payload demonstrates efficacy in ALK-expressing cancers
2025
·
Alberto D. Guerra
, Smita Matkar
, et al.
·
Nature Communications
·
9
PDF
Fibroblast-associated protein-α expression and BPV nucleic acid distribution in equine sarcoids
2021
·
Giorgia Tura
, Federica Savini
, et al.
·
Veterinary Pathology
·
7
Neuregulin 4 Boosts the Efficacy of Anti-ERBB2 Neutralizing Antibodies
2022
·
Carmen Miano
, Donatella Romaniello
, et al.
·
Frontiers in Oncology
·
6
PDF
Synergic activity of FGFR2 and MEK inhibitors in the treatment of FGFR2-amplified cancers of unknown primary
2024
·
Andrea Cavazzoni
, Irene Salamon
, et al.
·
Molecular Therapy
·
5
NF-kB oscillation profiles decode response to anti-EGFR monoclonal antibodies
2025
·
Donatella Romaniello
, Lorenzo Dall'Olio
, et al.
·
SLAS DISCOVERY
·
2
PDF
The therapeutic exploitation of IL-1 in cancer: Controlling tumor progression and resistance to targeted therapies
2026
·
Valerio Gelfo
, Federica Pagano
, et al.
·
Seminars in Immunology
·
1
Neuroendocrine-like/EMT dedifferentiation mediates resistance to EGFR inhibitors via the NRG1/HER3 axis
2026
·
Alessandra Morselli
, Chiara Miroglio
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
1
IL-1-mediated inflammation promotes metastatic dissemination and resistance to EGFR-targeted therapy
2026
·
Federica Pagano
, Cinzia Girone
, et al.
·
npj Precision Oncology
·
1
Nuclear Mechanotransduction at the Crossroads: How Membrane Receptors Remodel the Perinuclear Cytoskeleton to Drive Cancer and Disease
2026
·
Michela Sgarzi
, Elisa Montacci
, et al.
·
International Journal of Biological Sciences
Abstract 539: Secretory EMT fuels ERBB3 axis activation in resistance to EGFR inhibitors
2025
·
Alessandra Morselli
, Donatella Romaniello
, et al.
·
Cancer Research
Activation of ALK Signaling Pathway Induces DNA Damage Response in Colorectal Cancer
2024
·
Cinzia Girone
, Martina Mazzeschi
, et al.
·
Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna)
P-109 Broaden the therapeutic opportunities for colorectal cancer: ALK inhibition benefits consensus molecular subtype 1 patients
2023
·
M. Mazzeschi
, M. Sgarzi
, et al.
·
Annals of Oncology
PDF
The impact of glucocorticoids on Neuregulin-1/ERBB2 signaling in cardiomyocyte proliferation and heart regeneration
2020
·
Nicola Pianca
, Francesca Pontis
, et al.
·
Journal of Molecular and Cellular Cardiology
Modulation of ERBB signaling from tissue homeostasis to cancer progression
2018
·
Valerio Gelfo
, Giada Grilli
, et al.
·
Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna)
Molecular mechanisms of resistance to cetuximab mediated by IL-1 signaling
2018
·
Valerio Gelfo
, Giada Grilli
, et al.
·
Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna)
Show more works
View as search
Works count:
51
Citation count:
454
H-index:
10
I10-index:
10
Year
Topic
Type